NewGenIvf Group Ltd (NIVF)
Company
NewGenIvf Group Ltd (NIVF)
SPAC: ASPAC I Acquisition Corp. (ASCA)
Apr 04, 2024
Health
Merger / DESPAC- SPAC/IPOIPOFeb 2022SPAC/IPOIPOFeb 2022
- LOILOILOILOI
- AgreementDealFeb 2023AgreementDealFeb 2023
- Merger voteVoteMar 2024Merger voteVoteMar 2024
- MergerMergerApr 2024MergerMergerApr 2024
Merger · Apr 2024
SPAC/IPO details
A unit bundles the listed securities. Its components may become separately tradable after a period specified in the prospectus, even before a business combination. Units still outstanding at the business combination are generally separated into their components. Check the relevant SEC filings for the timing and procedure.
After a successful business combination, rights convert into shares at the stated ratio. Some structures require holders to request conversion; fractional shares and other terms are set out in the relevant SEC filing.
Only whole warrants can be exercised; fractional warrants per unit require multiple units to make a whole warrant. Warrants commonly allow holders to buy shares after a business combination at a set exercise price, often USD 11.50. They often last up to five years but may be redeemed earlier. Exercise date, price and term can differ; consult the relevant SEC filings.
NewGen is a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments. With a mission to aid couples and individuals in building families regardless of fertility challenges, NewGen has dedicated itself to creating increased access to infertility treatment and providing comprehensive fertility services for its customers. NewGen’s management team collectively has over a decade of experience in the fertility industry. NewGen’s clinics are located in Thailand, Cambodia, and Kyrgyzstan, and present a full suite of services for its patients, including comprehensive infertility and assisted reproductive technology treatments, egg and sperm donation, and surrogacy, in the appropriate jurisdictions, respectively. To learn more, visit www.newgenivf.com. The information contained on, or accessible through, NewGen’s website is not incorporated by reference into this press release, and you should not consider it a part of this press release.
Former names
| Name | Until |
|---|---|
| ASPAC I Mini Acquisition Corp. | Mar 1, 2024 |
Former names
| Name | Until |
|---|---|
| SPAC I Acquisition Corp. | Jun 23, 2021 |
Chart/Sentiment
Financials
NewGenIvf Group Ltd (NIVF)
| Period end | Revenue |
|---|---|
2025-12-3120-F | 23.7 m USD |
2024-12-3120-F | 371,666 USD |
2023-12-3120-F/A | 446,004 USD |
2022-12-3120-F/A | 506,343 USD |
2021-12-3120-F | 4.1 m USD |
Source: SEC Company Facts · USD. Some values may be calculated; please verify them against the official SEC filings.
ASPAC I Acquisition Corp. (ASCA)
Historical SPAC data
| Period end | Trust Assets |
|---|---|
2023-12-3110-K | 21.3 m USD |
2022-12-3110-K | 70.7 m USD |
Source: SEC Company Facts · USD. Some values may be calculated; please verify them against the official SEC filings.
- Trust assetsFunds held in trust for redemptions or the merger.
- 21.3 m USD2023-12-31
- Change in trust assetsPercentage change from the previous reported trust value.
- -69.9 %since 2022-12-31 · 2023-12-31
- Trust change since first reportPercentage change from the first reported trust value.
- -69.9 %First trust value 2022-12-31 · 70.7 m USD · 2023-12-31
Source: SEC Company Facts. Please verify calculated values against official filings.











